Naglaa Allam

537 total citations
25 papers, 364 citations indexed

About

Naglaa Allam is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Naglaa Allam has authored 25 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Naglaa Allam's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Naglaa Allam is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Naglaa Allam collaborates with scholars based in Egypt, Saudi Arabia and Canada. Naglaa Allam's co-authors include Imam Waked, Asmaa Gomaa, Aisha Elsharkawy, Mohamed El‐Kassas, Hatem Khalaf, Omar Elshaarawy, Gamal Esmat, Tarik Asselah, Gamal Shiha and Ayman Yosry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Transplantation.

In The Last Decade

Naglaa Allam

24 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naglaa Allam Egypt 10 272 259 61 31 22 25 364
Sylvia Dražilová Slovakia 12 255 0.9× 274 1.1× 94 1.5× 18 0.6× 17 0.8× 45 441
Rajani Sharma United States 11 180 0.7× 286 1.1× 82 1.3× 27 0.9× 21 1.0× 27 381
Nathan J. Shores United States 11 175 0.6× 162 0.6× 75 1.2× 40 1.3× 18 0.8× 23 320
Olivier Deckmyn France 12 417 1.5× 524 2.0× 51 0.8× 32 1.0× 18 0.8× 23 603
Susana Llerena Spain 12 304 1.1× 338 1.3× 32 0.5× 48 1.5× 39 1.8× 36 473
Waleed Al–Hamoudi Saudi Arabia 14 322 1.2× 362 1.4× 26 0.4× 23 0.7× 21 1.0× 29 424
José Ignacio Fortea Spain 12 385 1.4× 409 1.6× 102 1.7× 55 1.8× 43 2.0× 45 582
Zunirah Ahmed United States 9 190 0.7× 239 0.9× 61 1.0× 57 1.8× 15 0.7× 25 385
Serhat Aytug United States 6 214 0.8× 219 0.8× 55 0.9× 37 1.2× 9 0.4× 7 337
Nehad Hawash Egypt 10 224 0.8× 237 0.9× 59 1.0× 60 1.9× 16 0.7× 27 357

Countries citing papers authored by Naglaa Allam

Since Specialization
Citations

This map shows the geographic impact of Naglaa Allam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naglaa Allam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naglaa Allam more than expected).

Fields of papers citing papers by Naglaa Allam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naglaa Allam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naglaa Allam. The network helps show where Naglaa Allam may publish in the future.

Co-authorship network of co-authors of Naglaa Allam

This figure shows the co-authorship network connecting the top 25 collaborators of Naglaa Allam. A scholar is included among the top collaborators of Naglaa Allam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naglaa Allam. Naglaa Allam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allam, Naglaa, et al.. (2021). Ravidasvir hydrochloride for genotype 1 hepatitis C treatment. Drugs of today. 57(3). 199–199. 1 indexed citations
2.
Elshaarawy, Omar, Naglaa Allam, Eman Abdelsameea, Asmaa Gomaa, & Imam Waked. (2020). Platelet-albumin-bilirubin score - a predictor of outcome of acute variceal bleeding in patients with cirrhosis. World Journal of Hepatology. 12(3). 99–107. 19 indexed citations
3.
4.
Gomaa, Asmaa, Naglaa Allam, Aisha Elsharkawy, Mohamed El‐Kassas, & Imam Waked. (2017). Hepatitis C infection in Egypt: prevalence, impact and management strategies. SHILAP Revista de lepidopterología. Volume 9. 17–25. 135 indexed citations
5.
Esmat, Gamal, Tamer Elbaz, Maissa El Raziky, et al.. (2017). Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4. Journal of Hepatology. 68(1). 53–62. 12 indexed citations
6.
Allam, Naglaa. (2017). Advances in Treatment of Hepatitis C and B. InTech eBooks. 3 indexed citations
7.
Elshaarawy, Omar, et al.. (2017). PALBI - the platelet-albumin-bilirubin score – a better predictor of outcome of acute variceal bleeding. Journal of Hepatology. 66(1). S564–S564. 3 indexed citations
8.
9.
Al-hamoudi, Waleed, Faisal Abaalkhail, Naglaa Allam, et al.. (2015). The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool. Hepatology International. 10(2). 347–354. 9 indexed citations
10.
Allam, Naglaa, et al.. (2015). Noninvasive markers of liver disease in patients with HBeAg negative chronic hepatitis B and normal enzymes. Egyptian Liver Journal. 5(4). 68–72. 1 indexed citations
11.
Gomaa, Asmaa, et al.. (2015). Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy. Asian Pacific Journal of Cancer Prevention. 16(16). 6929–6934. 3 indexed citations
12.
Hegab, Bassem, Hatem Khalaf, Naglaa Allam, et al.. (2012). De novo malignancies after liver transplantation: a single-center experience. Annals of Saudi Medicine. 32(4). 355–358. 5 indexed citations
13.
Khalaf, Hatem, et al.. (2012). Coincidental Occurrence of Hepatocellular Carcinoma and Cholangiocarcinoma (Collision Tumors) After Liver Transplantation: A Case Report. Hepatitis Monthly. 12(10 HCC). e5871–e5871. 4 indexed citations
14.
Al-hamoudi, Waleed, Faisal Abaalkhail, Naglaa Allam, et al.. (2011). Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin. Digestive Diseases and Sciences. 56(6). 1848–1852. 9 indexed citations
15.
Allam, Naglaa, et al.. (2010). Study of adiponectin in chronic liver disease and cholestasis. Hepatology International. 4(4). 767–774. 26 indexed citations
16.
Allam, Naglaa, Hatem Khalaf, A Helmy, et al.. (2010). Clinical Outcomes for Saudi and Egyptian Patients Receiving Deceased Donor Liver Transplantation in China. American Journal of Transplantation. 10(8). 1834–1841. 19 indexed citations
17.
Abdeldayem, Hesham, et al.. (2008). MORAL AND ETHICAL ISSUES IN LIVER TRANSPLANTATION IN EGYPT. Transplantation. 86(2S). 593–593. 1 indexed citations
18.
Allam, Naglaa, et al.. (2008). Liver transplant for hepatocellular carcinoma: experience in a Saudi population.. PubMed. 6(1). 14–24. 6 indexed citations
19.
Khalaf, Hatem, et al.. (2008). Risk factors for biliary complications after living-donor liver transplant: a single-center experience.. PubMed. 6(2). 101–4. 6 indexed citations
20.
Ferraz, Henrique Ballalai, et al.. (2004). "High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. Brazilian Journal of Medical and Biological Research. 37(9). 1297–1302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Dražilová Breakdown of academic impact, for papers by Rajani Sharma Breakdown of academic impact, for papers by Nathan J. Shores Breakdown of academic impact, for papers by Olivier Deckmyn Breakdown of academic impact, for papers by Susana Llerena Breakdown of academic impact, for papers by Waleed Al–Hamoudi Breakdown of academic impact, for papers by José Ignacio Fortea Breakdown of academic impact, for papers by Zunirah Ahmed Breakdown of academic impact, for papers by Serhat Aytug Breakdown of academic impact, for papers by Nehad Hawash
Rankless by CCL
2026